Involvement of Monocytic B1 and B2 Receptors in Inflammation and Chronic Vascular Disease in Patients With Hereditary Bradykinetic Angioedema

Not Applicable

• Conditions: Hereditary Bradykinetic Angioedema
• Interventions: Other: Explorations; Other: Blood samples

• Registration Number: NCT04032002
• Lead Sponsor: University Hospital, Rouen

Brief Summary

The objective is to compare the gene expression of B1 and / or B2 monocyte receptors between patients with hereditary bradykinetic angioedema and control subjects.

Detailed Description

Not available

Study Timeline

• Status Verified: 2019-07
• Study First Submitted: 2019-07-22
• Study First Submitted QC: 2019-07-22
• Study First Posted: 2019-07-25
• Study Start: 2019-10
• Last Update Submitted: 2019-10-16
• Last Update Posted: 2019-10-17
• Primary Completion: 2021-09
• Study Completion: 2021-09

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Patients hereditary bradykinetic angioedema	Blood samples	-
healthy volunteers	Blood samples	-
Patients hereditary bradykinetic angioedema	Explorations	-
healthy volunteers	Explorations	-

Primary Outcome Measures

Name	Time	Method
compare the gene expression of B1 and / or B2 monocyte receptors	Day 1	compare between patients with hereditary bradykinetic angioedema and control subjects.

Trial Locations

Locations (1)

DRCI; 🇫🇷 Rouen, France